D81.82 - Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]

  • Applicable to Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]
  • The 2025 edition of ICD10-CM D81.82 became effective on October 1, 2024.
  • This is the American ICD10-CM version of D81.82 - other international versions of ICD10 D81.82 may differ.
  • D81.82 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

 Inclusion Term

  • p110d-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency [PASLI] disease

codeAlso

  • , if applicable, any associated manifestations, such as:
  • bronchiectasis (J47.-)
  • herpes virus infections (B00.-)
  • other acute respiratory tract infections (J00-J06; J20-J22)
  • other infections (A00-B99)
  • pneumonia (J12-J18)

The following codes above D81.82 contain annotation back-references that may be applicable to D81.82:

Chapter: D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Section: D80-D89 Certain disorders involving the immune mechanism

Category: D81 Combined immunodeficiencies

delta icd 10
 
syndrome icd 10
 
activated icd 10
 
phosphoinositide icd 10
 
Billable/Specific Code

Browse other similar CM codes

D81.0
 
D81.1
 
D81.2
 
D81.3
 
D81.30
 
D81.31
 
D81.32
 
D81.39
 
D81.4
 
D81.5
 
D81.6
 
D81.7
 
D81.8
 
D81.81
 
D81.810
 
D81.818
 
D81.819
 
D81.82
 
D81.89
 
D81.9
 

Please, give attribution to our website icd-10code.com